Key model inputs
| Parameter . | Value . | Range considered in sensitivity analysis . | Original model inputs∗ . | References . |
|---|---|---|---|---|
| Percentage of patients with severe phenotype | 35% | 20%-60% | 25% (10%-40%) | 8,9 |
| Baseline annual expenditure for patient with SCD† | $51 700 | $21 830-$85 680 | $48 900 ($19 900-$78 100) | 13,14 |
| Cost of single gene therapy treatment per person (million) | $2.29 | $1.78-$3.19 | $2.267 ($1.769-$2.659) | 7,11,12 |
| Annual market diffusion rate for gene therapy | 7% | 2%-15% | 7% (2%-15%) | Assumed |
| Parameter . | Value . | Range considered in sensitivity analysis . | Original model inputs∗ . | References . |
|---|---|---|---|---|
| Percentage of patients with severe phenotype | 35% | 20%-60% | 25% (10%-40%) | 8,9 |
| Baseline annual expenditure for patient with SCD† | $51 700 | $21 830-$85 680 | $48 900 ($19 900-$78 100) | 13,14 |
| Cost of single gene therapy treatment per person (million) | $2.29 | $1.78-$3.19 | $2.267 ($1.769-$2.659) | 7,11,12 |
| Annual market diffusion rate for gene therapy | 7% | 2%-15% | 7% (2%-15%) | Assumed |